11:13 AM EDT, 05/10/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.60 to 1,414.50 on the S&P Europe Select ADR Index. With the gain, the index is poised to end the week around 2.7% higher.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and kidney dialysis company Fresenius Medical Care ( FMS ) , which rose 6.2% and 4.7%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which increased 2.5% and 2.3%, respectively.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis ( CLLS ) and argenx (ARGX), which fell 3.3% and 1.9%, respectively. They were followed by telecommunications operator Telefonica ( TEF ) and internet advertising firm Criteo ( CRTO ) , which were down 1.4% and 1%, respectively.

From the UK and Ireland, the gainers were led by construction materials supplier CRH (CRH) and biotech firm Trinity Biotech ( TRIB ) , which rose 5.3% and 3%, respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals ( AVDL ) and biopharmaceutical company Amarin Corporation ( AMRN ) , which were up 2.5% and 1.1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which lost 4.9% and 4.3%, respectively. They were followed by biopharmaceutical companies NuCana ( NCNA ) and Mereo BioPharma Group ( MREO ) , which dropped 2.6% and 2%, respectively.